B. Ammentorp

Efficacy and Tolerability of Triple‐Combination Therapy With Olmesartan, Amlodipine, and Hydrochlorothiazide: A Subgroup Analysis of Patients Stratified by Hypertension Severity, Age, Sex, and Obesity

A. de la Sierra, R. Kreutz, B. Ammentorp, 2014, Journal of clinical hypertension.

Adding Hydrochlorothiazide to Olmesartan/Amlodipine Increases Efficacy in Patients With Inadequate Blood Pressure Control on Dual‐Combination Therapy

L. Rump, B. Ammentorp, P. Laeis, 2015, Journal of clinical hypertension.

Open-Label Study Assessing the Long-term Efficacy and Safety of Triple Olmesartan/Amlodipine/Hydrochlorothiazide Combination Therapy for Hypertension

M. Volpe, A. Sierra, B. Ammentorp, 2014, Advances in Therapy.

Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan / Amlodipine / Hydrochlorothiazide Combination

M. Volpe, L. Rump, B. Ammentorp, 2012 .

Efficacy and safety of triple antihypertensive therapy with the olmesartan/amlodipine/hydrochlorothiazide combination.

M. Volpe, B. Ammentorp, P. Laeis, 2012, Clinical drug investigation.

Frequent and possibly inappropriate use of combination therapy with an oral anticoagulant and antiplatelet agents in patients with atrial fibrillation in Europe

P. Kirchhof, R. de Caterina, J. Le Heuzey, 2014, Heart.

Management of atrial fibrillation in seven European countries after the publication of the 2010 ESC Guidelines on atrial fibrillation: primary results of the PREvention oF thromboemolic events—European Registry in Atrial Fibrillation (PREFER in AF)

P. Kirchhof, R. de Caterina, J. Le Heuzey, 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Differences among western European countries in anticoagulation management of atrial fibrillation

P. Kirchhof, R. de Caterina, J. Le Heuzey, 2014, Thrombosis and Haemostasis.

Anticoagulation management in atrial fibrillation: inter-country differences in Western Europe: data from the PREFER in AF registry

P. Kirchhof, J. Zamorano, H. Darius, 2013 .

Efficacy and Safety of Triple Antihypertensive Therapy with the Olmesartan/Amlodipine/Hydrochlorothiazide Combination

M. Volpe, B. Ammentorp, P. Laeis, 2012, Clinical Drug Investigation.